|
Volumn 141, Issue 5, 2008, Pages 744-745
|
Gemtuzumab ozogamicin plus cytarabine in elderly patients with relapsed or refractory acute myeloid leukaemia
|
Author keywords
Acute myeloid leukaemia; Cytarabine; Elderly; Gemtuzumab ozogamicin; Refractory leukaemia
|
Indexed keywords
CYTARABINE;
GEMTUZUMAB OZOGAMICIN;
MITOXANTRONE;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
AGED;
BRAIN HEMORRHAGE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CHOLESTASIS;
CLINICAL ARTICLE;
CONTINUOUS INFUSION;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
HYPERBILIRUBINEMIA;
LETTER;
LEUKEMIA RELAPSE;
LEUKEMIA REMISSION;
LIVER TOXICITY;
LOW DRUG DOSE;
MALE;
METABOLIC ACIDOSIS;
MULTIPLE CYCLE TREATMENT;
PRIORITY JOURNAL;
SEPTIC SHOCK;
TREATMENT RESPONSE;
VEIN OCCLUSION;
AGED;
AMINOGLYCOSIDES;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYTARABINE;
FEMALE;
HUMANS;
LEUKEMIA, MYELOID, ACUTE;
MALE;
MIDDLE AGED;
RECURRENCE;
TREATMENT OUTCOME;
|
EID: 43449121559
PISSN: 00071048
EISSN: 13652141
Source Type: Journal
DOI: 10.1111/j.1365-2141.2008.07096.x Document Type: Letter |
Times cited : (5)
|
References (5)
|